Interestingly, pharmacological inhibition or gene silencing of MT1-MMP has been shown to potentiate antiglioma therapies using either combined temozolomide/radiation therapy [47] or glioma virotherapy [48]. This evidence concerns the gene MMP14 and central nervous system cancer.